Related Experiment Video
Updated: Jan 14, 2026

07:21
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
Published on: June 16, 2023
1.4K
A PLAN to address the Parkinson pandemic
E Ray Dorsey1,2, Michael S Okun3, Bastiaan R Bloem4
1Atria Health and Research Institute, New York, NY, USA.
Journal of Parkinson'S Disease
|October 21, 2025
Summary
The Parkinson pandemic is worsening, with environmental toxicants like pesticides and air pollution playing a key role. A comprehensive plan is needed to prevent Parkinson's disease, fund research, and improve care for millions affected.
Area of Science:
- Neuroscience
- Environmental Health
- Public Health
Background:
- Parkinson's disease is a growing global pandemic, affecting nearly 12 million individuals.
- Environmental toxicants, including pesticides, dry-cleaning chemicals, and air pollution, are increasingly linked to Parkinson's etiology.
- Emerging models suggest Parkinson's may originate in the brain and body due to toxicant exposure.
Purpose of the Study:
- To outline a "PLAN" to address the Parkinson pandemic.
- To emphasize prevention, understanding disease origins, amplifying patient voices, and advancing treatments.
- To establish ambitious 0-10-100 goals by 2035 for Parkinson's disease control.
Main Methods:
- The study proposes a multi-faceted approach focusing on reducing toxicant exposure.
- Investigating environmental exposures, gene-environment interactions, and disease modifiers.
- Expanding research funding and prioritizing prevention research.
Main Results:
- A proposed "PLAN" aims to prevent Parkinson's disease, understand its causes, support patients, and improve treatments.
- Key goals by 2035 include a 0% rise in incidence, a 10-fold increase in research funding (with a focus on prevention), and 100% access to care.
- Reducing environmental toxicants is crucial for slowing the disease's progression.
Conclusions:
- A proactive, comprehensive plan is essential to combat the rising Parkinson pandemic.
- Addressing environmental factors and increasing research are critical steps toward controlling Parkinson's disease.
- The proposed goals provide a framework for significant advancements in Parkinson's prevention and treatment by 2035.
Related Concept Videos
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Steps in Outbreak Investigation
487
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
487
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
Pneumonia V: Nursing management and Prevention
3.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K

